z-logo
open-access-imgOpen Access
Alectinib Together with Intracranial Therapies Improved Survival Outcomes in Untreated ALK-Positive Patients with Non-Small-Cell Lung Cancer and Symptomatic and Synchronic Brain Metastases: A Retrospective Study
Author(s) -
Qiang Yin,
Peng Li,
Peng Wang,
Zhen Zhang,
Qun Liu,
Zengfeng Sun,
Wenliang Li,
Li Ma,
Xiaoguang Wang
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s345439
Subject(s) - alectinib , crizotinib , medicine , anaplastic lymphoma kinase , lung cancer , alk inhibitor , oncology , retrospective cohort study , brain metastasis , gastroenterology , surgery , cancer , metastasis , malignant pleural effusion

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here